News
Venture Challenge alumnus MyLife Technologies raises €3.5 million to develop its vaccine delivery technology via ceramic vaccine patches for 'Pandemic Preparedness'
Leiden, – MyLife Technologies, which focuses on the development of ceramic vaccine patches for the simple, efficient and painless administration of vaccines through the skin, has raised €3.5 million from Fare Capital BV, SAL Beheer BV, informal inve
Venture Challenge Winner SeraNovo Enters into License Agreement with Équilibre BioPharmaceuticals.
SeraNovo BV (Leiden, The Netherlands) is pleased to announce the closing of a License Agreement with Équilibre BioPharmaceuticals Corporation (New York, USA), a biopharmaceutical company engaged in the research and development of small molecules in
Venture Challenge alumnus Scope Biosciences raises €1 Million funding from GenDx
WAGENINGEN - Diagnostic startup company Scope Biosciences B.V. has raised €1 Million funding from Utrecht based GenDx, specialized in Next Generation Sequencing (NGS) products for transplant diagnostics.
Venture Challenge alumnus Praxa Sense initiates first clinical trial
Last month, Praxa Sense has started the first clinical trial with their Afi product at Reinier de Graaf ziekenhuis.
Venture Challenge alumnus BIMINI Biotech closes seed investment with Libertatis Ergo Holding
Leiden – BIMINI Biotech, an innovative therapeutics start-up that develops new cancer drugs, raised an investment of €250,000. The seed funding is provided by Libertatis Ergo Holding B.V.
Venture Challenge alumnus Mercurna reaches important scientific and IP milestones
Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead formulation for chronic kidney disease.
Last chance to signup for the Paul Janssen Futurelab IP Course
The Paul Janssen Futurelab Intellectual Property Online course will start next Monday on October 11.
Venture Challenge alumnus NTRC spins-out Oncolines
As an independent company, Oncolines will now be singularly focused on offering the best precision medicine services in oncology and cancer immunotherapy for our clients.
Venture Challenge alumnus Nutrileads launches clinically backed BeniCaros™ for sustainable, year-round immune support
Wageningen, The Netherlands – Dutch health ingredients company, NutriLeads, announced the launch of its proprietary immune health ingredient, BeniCaros™.
ShanX Medtech recognized as a Deep Tech Pioneer by Hello Tomorrow
ShanX Medtech is delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that they have been recognised by Hello Tomorrow as 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘮𝘰𝘴𝘵 𝘱𝘳𝘰𝘮𝘪𝘴𝘪𝘯𝘨 𝘱𝘳𝘰𝘫𝘦𝘤𝘵𝘴 𝘪𝘯 𝘥𝘦𝘦𝘱 𝘵𝘦𝘤𝘩 𝘵𝘰 𝘥𝘢𝘵𝘦.